# Semaglutide Hair Loss: Why It Happens & What to Do **By TelosRX Editorial Team** · 2026-08-16 **Semaglutide can cause temporary hair loss — typically telogen effluvium — in roughly 3 percent of users, according to clinical reports. The shedding usually peaks at two to four months and resolves on its own. [TelosRX](https://telosrx.com) providers can help you address contributing nutritional gaps.** ## What Is Semaglutide Hair Loss? Hair loss associated with semaglutide (the active ingredient in Ozempic® and Wegovy®) is classified as telogen effluvium — a diffuse, temporary shedding triggered by a physiological stressor rather than a structural change to the follicle. It is not the same as androgenetic alopecia (pattern baldness), and the follicle itself is not destroyed. Post-marketing surveillance data submitted to the FDA Adverse Event Reporting System (FAERS) identified alopecia as a reportable event for semaglutide users, with rates modestly higher than background for people losing significant body weight rapidly. A 2025 letter in the _Journal of the American Academy of Dermatology_ described the pattern as consistent with nutritional-deficit telogen effluvium rather than drug toxicity to the hair follicle. Key points: - Onset typically 2–4 months after initiating semaglutide or after a significant weight-loss acceleration - Shedding is diffuse, not patchy - The hair cycle self-corrects in most cases within 6–12 months - The condition is not predictive of permanent hair loss ## Why Does It Happen? Telogen Effluvium Explained Human hair grows in three phases: anagen (active growth), catagen (transition), and telogen (resting/shedding). At any point, roughly 85–90 percent of scalp hairs are in anagen. A significant physiological stress — rapid caloric restriction, surgery, illness, or dramatic weight change — can push a larger-than-normal cohort of follicles into telogen simultaneously. The result is a noticeable increase in shed hairs two to four months later, when those resting follicles release their shafts. Rapid caloric deficit is the primary driver in GLP-1 users. Semaglutide suppresses appetite substantially, and some users reduce caloric intake by 30–50 percent within weeks of dose escalation. This creates a physiological environment similar to the post-surgical or post-illness hair loss pattern well-documented in bariatric surgery literature. The drug itself does not appear to be directly toxic to follicles. Research has noted that when protein intake was maintained and micronutrient deficiencies corrected, the telogen effluvium pattern resolved faster and with less overall shedding than in matched controls who did not address nutritional factors. ## Nutritional Deficiencies That Amplify Hair Loss on Semaglutide Because semaglutide reduces overall food intake, users eating a low-volume diet may develop sub-clinical deficiencies that compound follicle stress. The most commonly implicated micronutrients: Nutrient Role in Hair Cycle Dietary Source Protein / amino acids Hair shaft is approximately 90% keratin; inadequate protein shortens anagen Chicken, eggs, Greek yogurt, legumes Iron (ferritin) Low ferritin is the most studied nutritional trigger for telogen effluvium in women Red meat, lentils, fortified cereals Zinc Supports keratinocyte proliferation; deficiency accelerates shedding Oysters, pumpkin seeds, beef Biotin (B7) Cofactor for keratin synthesis; frank deficiency is rare but can occur on very low-calorie diets Eggs, almonds, sweet potato Vitamin D Vitamin D receptors are expressed in hair follicles; low levels associated with increased shedding Fatty fish, fortified milk, sunlight A provider-ordered lab panel — ferritin, complete blood count, 25-OH vitamin D, zinc, and a comprehensive metabolic panel — can identify specific deficiencies to address rather than guessing with a supplement stack. ## Hormonal and Metabolic Factors Beyond nutrition, semaglutide’s downstream hormonal effects may interact with hair cycling in some individuals: - **Insulin sensitivity improvement:** As insulin resistance improves, androgen metabolism can shift. For people with polycystic ovary syndrome (PCOS) or elevated androgens, this shift may initially disrupt the follicle environment before ultimately benefiting it. - **Thyroid axis:** Weight loss can alter T3/T4 conversion efficiency. Subclinical hypothyroidism — already a common cause of hair thinning — may be unmasked or worsen during rapid weight loss phases. - **Stress hormones:** Cortisol elevation, common during caloric restriction, can compress the anagen phase and drive more follicles into telogen. These factors underscore why a comprehensive evaluation is more useful than a one-size-fits-all supplement protocol. A licensed provider can review labs for thyroid function, androgens, and inflammatory markers alongside the standard micronutrient panel. ## What to Do About Semaglutide Hair Loss There is no single intervention that stops telogen effluvium on a fixed schedule — the follicle cycle must complete. However, several evidence-supported strategies can reduce severity and shorten duration, subject to evaluation by a licensed provider: 1. **Maintain adequate protein intake.** Aim for 1.2–1.6 g of protein per kilogram of body weight daily, even on reduced-calorie eating. Protein quality and distribution across meals matter; a registered dietitian familiar with GLP-1 users can help plan this. 2. **Identify and correct specific deficiencies.** Lab-directed supplementation of iron (if ferritin is low), vitamin D, or zinc is more targeted than a broad multivitamin. Over-supplementing biotin can interfere with thyroid lab assays — another reason to test before supplementing. 3. **Avoid dramatic calorie restriction phases.** If shedding is significant, discuss a temporary caloric floor with your provider. Slowing the pace of weight loss can reduce the physiological stress signal reaching follicles. 4. **Consider scalp support therapies.** Minoxidil (topical) has evidence for telogen effluvium in some populations and may be appropriate for some patients — subject to provider evaluation and approval. 5. **Allow the cycle to complete.** Most telogen effluvium resolves within 6–12 months of onset, even without intervention, provided the underlying stressor is addressed. Realistic expectations set by a provider are part of the protocol. TelosRX providers can review your GLP-1 protocol, order appropriate labs, and recommend tailored next steps through an asynchronous online consultation — no in-person visit or real-time call required. [Start your evaluation at TelosRX](https://telosrx.com). ## Semaglutide Hair Loss vs. Tirzepatide: Quick Comparison Factor Semaglutide (Ozempic / Wegovy) Tirzepatide (Mounjaro / Zepbound) Reported hair shedding rate (FAERS) ~3% of weight-management users ~2.5% (early post-marketing data) Primary mechanism GLP-1 receptor agonist GLP-1 + GIP dual agonist Average weight loss (%) ~15% body weight (Wegovy trials) ~20–22% body weight (SURMOUNT trials) Hair loss pattern Telogen effluvium; nutritional Similar; larger weight loss may increase risk Reversibility Yes, typically 6–12 months Yes; timeline similar Because tirzepatide produces larger average weight loss, some researchers have theorized that the telogen effluvium risk may be marginally higher — but direct head-to-head comparative data are not yet available. ## Frequently Asked Questions ### Will I definitely lose hair on semaglutide? No. Hair loss is reported by a minority of users — roughly 3 percent in post-marketing data. Most people do not experience clinically noticeable shedding. Maintaining protein intake and addressing micronutrient deficiencies lowers the risk further. ### How long does semaglutide hair loss last? Telogen effluvium triggered by rapid weight loss typically resolves within 6–12 months of onset, once the follicle cycle completes and nutritional balance is restored. Individual timelines vary and depend on whether underlying deficiencies are corrected. ### Should I stop taking semaglutide if I am losing hair? Do not stop or modify your medication without consulting your prescribing provider. Hair shedding alone is generally not a medical reason to discontinue semaglutide. A provider can assess whether the shedding warrants a dosing pause or protocol adjustment. ### Does taking biotin help with semaglutide hair loss? Biotin supplementation is widely marketed for hair health but has limited clinical evidence for telogen effluvium unless you have a frank biotin deficiency, which is uncommon. High-dose biotin can also interfere with thyroid and troponin lab assays, so consult a provider before supplementing. ### Can a provider prescribe something for the hair loss? Topical minoxidil has evidence for accelerating telogen effluvium recovery in some patients and may be appropriate subject to provider evaluation and approval. A licensed TelosRX provider can review your case asynchronously and determine whether a prescription intervention is indicated. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ **Tags:** GLP-1, hair loss, nutrition, ozempic, semaglutide, telogen effluvium, wegovy, weight loss --- > Source: [Telos RX](https://www.telosrx.com/blogs/glp1/semaglutide-hair-loss-explained)